This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Nagao, S.-i. Articles by Osada, Y. Search for Related Content PubMed PubMed Citation Articles by Nagao, S.-i. Articles by Osada, Y.

Binding of Human -Interferon to Human Epidermal Tumor Cells with Different Susceptibilities

Research Institute, Daiichi Seiyaku Co., Ltd., 1-16-13, Kitakasai, Edogawa-ku, Tokyo 134, Japan

The in vitro antiproliferative effect of highly purified recombinant human -interferon was studied with special reference to specific binding to tumor cells of interferon (IFN) labeled with ¹²⁵I. Recombinant human -interferon markedly suppressed the growth of 6 of 10 human epidermal tumor cell lines tested; the concentration required to inhibit the growth of susceptible cell lines by 50% ranged from 8 to 36 units/ml (13.6 to 61.2 pM), whereas those for the other cell lines were higher than 10,000 units/ml. These anticellular effects were compatible with the suppressive effects of IFN on cellular DNA synthesis. Labeled IFN bound specifically to the susceptible cells, which showed, from the Scatchard analysis, 870 to 7700 binding sites/cell with apparent K_d of 1.70 to 5.84 x 10^-11 M. There was little binding of the labeled IFN to the resistant cells and nonspecific binding occurring in the presence of a 1000-fold excess of unlabeled IFN accounted for 40 to 90% of the total binding. These results suggest that specific binding sites for recombinant human -interferon exist on the resistant cell lines.

¹ To whom requests for reprints should be addressed.

Received 6/11/85. Revised 11/12/85. Revised 3/11/86. Accepted 3/17/86.